Ad
related to: scip measures vte risk factors and prevention strategies for cancer
Search results
Results From The WOW.Com Content Network
The Surgical Care Improvement Project (SCIP) partnership is an American multi-year national campaign to substantially reduce surgical mortality and morbidity through collaborative efforts between healthcare organizations. The campaign began in August 2005 with the original goal of reducing the national incidence of surgical complications by 25% ...
Studies of the pathophysiologic mechanisms for the increased risk of venous thromboembolism or VTE after long-distance travel have not produced consistent results, but venous stasis appears to play a major role; other factors specific to air travel may increase coagulation activation, particularly in passengers with individual risk factors for VTE.
People who have cancer have a higher risk of VTE and may respond differently to anticoagulant preventative treatments and prevention measures. [36] The American Society of Hematology strongly suggests that people undergoing chemotherapy for cancer who are at low risk of a VTE avoid medications to prevent thrombosis (thromboprophylaxis). [37]
The mainstay of VTE management is anticoagulation therapy, which prevents thrombus propagation and embolization. Such treatment reduces the risk of recurrence. [5] [4] [1] The choice and duration of anticoagulation depend on the individual patient's risk factors, bleeding risk, and preferences.
Dozens of genetic risk factors have been identified, [14] and they account for approximately 50 to 60% of the variability in VTE rates. [4] As such, family history of VTE is a risk factor for a first VTE. [88] Factor V Leiden, which makes factor V resistant to inactivation by activated protein C, [88] mildly increases VTE risk by about three times.
Cancer prevention is the practice of taking active measures to decrease the incidence of cancer and mortality. [ 1 ] [ 2 ] The practice of prevention depends on both individual efforts to improve lifestyle and seek preventive screening , and socioeconomic or public policy related to cancer prevention. [ 3 ]
The origin of the term "Virchow's Triad" is of historical interest, and has been subject to reinterpretation in recent years. [7] While both Virchow's and the modern triads describe thrombosis, the previous triad has been characterized as "the consequences of thrombosis", and the modern triad as "the causes of thrombosis".
Primordial prevention refers to all measures designed to prevent the development of risk factors in the first place, early in life, [16] [17] and even preconception, as Ruth A. Etzel has described it "all population-level actions and measures that inhibit the emergence and establishment of adverse environmental, economic, and social conditions".